Aubryn International Receives Positive Report on Jack Daniels; Quality and Quantity Levels Exceed Company's Expectations.Business Editors UPLAND, Calif.--(BUSINESS WIRE)--May 29, 2001 Aubryn International Inc. (ARBN ARBN Australian Registered Body Number ARBN Asian Rice Biotechnology Network ARBN Australian Registered Business Number ARBN African Rice Blast Nursery ) today announced that the company received the results from two labs, GSI GSI - Gensym Standard Interface Water Reports (Geology & Ground Reporting Co.) and National Testing Laboratories LTD LTD 1 Laron-type dwarfism 2 Leukotriene D 3 Long-term depression, see there 4. Long-term disability (Ypsilanti, Mich.), which have provided confirmation that the flow rate, quality and levels of water meets and exceeds expectations. The GSI/Water source conducted tests on the quality and quantity levels. These tests involve classifying the springs retaining FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. levels required for natural occurring springs. "These reports confirm the company's confidence in this new business line. In fact, with the quantity and quality levels of the springs exceeding the company's expectation, there is the possibility for upside in our estimates of revenue," stated CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. R.B. Harris. Forward-Looking Statements: This news release contains statements relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc future plans, events or performance that involve risks and uncertainties. The Issuer's expectations, among other things, are dependant upon general economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, as well as other uncontrollable or unknown factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Aubryn undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion